Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Human leukocyte and fibroblast interferon in a combination therapy of dendritic keratitis.

Literature DB >> 310269

Human leukocyte and fibroblast interferon in a combination therapy of dendritic keratitis.

R Sundmacher, K Cantell, R Skoda, C Hallermann, D Neumann-Haefelin.

Abstract

Thirty-eight patients with virologically proven dendritic keratitis were treated using either debridement plus human leukocyte interferon (HLI) or debridement plus human fibroblast interferon (HFI) in a randomized, double-blind study. We administered one drop of HLI or HFI (1 X 10(6) reference units/ml) daily and found no significant difference in the action of either type of interferon.

Entities: Disease Species

Mesh：

Substances：
Interferons

Year: 1978 PMID： 310269 DOI： 10.1007/bf00419377

Source DB: PubMed Journal: Albrecht Von Graefes Arch Klin Exp Ophthalmol ISSN： 0065-6100

8 in total

Review 1. Prospects for the clinical use of exogenous interferon.

Authors: K Cantell
Journal: Med Biol Date: 1977-04

2. Is interferon tissue specific?- Effect of human leukocyte and fibroblast interferons on the growth of lymphoblastoid and osteosarcoma cell lines.

Authors: S Einhorn; H Strander
Journal: J Gen Virol Date: 1977-06 Impact factor: 3.891

3. A micro assay for mouse and human interferon.

Authors: H Dahl; M Degré
Journal: Acta Pathol Microbiol Scand B Microbiol Immunol Date: 1972

4. Production of high-titered interferon in cultures of human diploid cells.

Authors: E A Havell; J Vilcek
Journal: Antimicrob Agents Chemother Date: 1972-12 Impact factor: 5.191

5. Role of debridement and interferon in the treatment of dendritic keratitis.

Authors: R Sundmacher; K Cantell; P Haug; D Neumann-Haefelin
Journal: Albrecht Von Graefes Arch Klin Exp Ophthalmol Date: 1978-07-17

6. Topical therapy of ulcerative herpetic keratitis with human interferon.

Authors: B R Jones; D J Coster; M G Falcon; K Cantell
Journal: Lancet Date: 1976-07-17 Impact factor: 79.321

7. Successful treatment of dendritic keratitis with human leukocyte interferon. A controlled clinical study.

Authors: R Sundmacher; D Neumann-Haefelin; K Cantell
Journal: Albrecht Von Graefes Arch Klin Exp Ophthalmol Date: 1976-11-18

8. Comparative evaluation of human leukocyte and fibroblast interferon in the prevention of herpes simplex virus keratitis in a monkey model.

Authors: D Neumann-Haefelin; R Sundmacher; R Skoda; K Cantell
Journal: Infect Immun Date: 1977-08 Impact factor: 3.441

8 in total

11 in total

Review 1. Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis.

Authors: Kirk R Wilhelmus
Journal: Cochrane Database Syst Rev Date: 2015-01-09

Review 2. Interferon associated retinopathy.

Authors: S Hayasaka; Y Nagaki; M Matsumoto; S Sato
Journal: Br J Ophthalmol Date: 1998-03 Impact factor: 4.638

3. Recombinant HuIFN-gamma prevents herpes simplex keratitis in African green monkeys: demonstration of synergism with recombinant HuIFN-alpha 2.

Authors: D Neumann-Haefelin; R Sundmacher; H Frey; W Merk
Journal: Med Microbiol Immunol Date: 1985 Impact factor: 3.402

9. Comparison of human fibroblast and leukocyte interferon in the treatment of severe laryngeal papillomatosis in children.

Authors: U Göbel; W Arnold; V Wahn; J Treuner; H Jürgens; K Cantell
Journal: Eur J Pediatr Date: 1981-10 Impact factor: 3.183

10. Interferon therapy and immunity.

Authors: D F Woodrow
Journal: J R Soc Med Date: 1983-03 Impact factor: 18.000